Mark Anthony McCamish

Insider Reports History

Entity
Individual
Location
C/O Forty Seven, Inc., 1490 O'brien Drive, Suite A, Menlo Park, CA
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Anthony McCamish:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AVADEL PHARMACEUTICALS PLC Director ADSs 67K $972K $14.50 Dec 28, 2023 By Matthew 5 LLC
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 67K $683K $10.19 Jul 30, 2024 By Matthew 5 LLC
AVADEL PHARMACEUTICALS PLC Director Ordinary Shares 11K $112K $10.19 Jul 30, 2024 Direct
Rafael Holdings, Inc. Director Class B Common Stock, par value $.01 per share 60.2K $109K $1.81 Jan 5, 2024 Direct
AVADEL PHARMACEUTICALS PLC Director Stock Option (Right to Buy) 11K Jul 30, 2024 Direct

Insider Reports Filed by Mark Anthony McCamish

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVDL AVADEL PHARMACEUTICALS PLC Jul 30, 2024 2 $0 4 Aug 1, 2024 Director
RFL Rafael Holdings, Inc. Jan 5, 2024 1 $50.1K 4 Jan 8, 2024 Director
AVDL AVADEL PHARMACEUTICALS PLC Dec 28, 2023 1 -$1.09M 4 Dec 29, 2023 Director
AVDL AVADEL PHARMACEUTICALS PLC Aug 11, 2023 1 -$433K 4 Aug 15, 2023 Director
AVDL AVADEL PHARMACEUTICALS PLC Aug 1, 2023 1 $0 4 Aug 3, 2023 Director
RFL Rafael Holdings, Inc. Jan 5, 2023 1 $50K 4 Jan 5, 2023 Director
AVDL AVADEL PHARMACEUTICALS PLC Aug 3, 2022 1 $0 4 Aug 5, 2022 Director
RFL Rafael Holdings, Inc. Jan 5, 2022 1 $29.2K 4 Jan 5, 2022 Director
AVDL AVADEL PHARMACEUTICALS PLC Aug 3, 2021 1 $0 4 Aug 5, 2021 Director
RFL Rafael Holdings, Inc. Jun 14, 2021 0 $0 3 Jun 22, 2021 Director